End
1 :

0900:

Client arrives to ED via ambulance with "racing heart" that began at 0100. Reports no chest pain or dyspnea.

Past medical history: hypertension, heart failure, obstructive sleep apnea, and hyperthyroidism.

Alert and oriented to person, place, and time. Respirations are tachypneic. Breath sounds are clear to auscultation bilaterally S1, S2 auscultated. Tachycardic rate. Irregular rhythm. Non- pitting pedal edema bilaterally.

0930:

Client called for nurse and states, they feel "heaviness in my chest" and "I feel anxious" and "it's difficult to catch my breath".

ECG: atrial fibrillation.

0900:

Temperature 36.5° C (97.7° F)

Heart rate 122/min Respiratory rate 22/min Blood pressure 132/68 mm Hg Oxygen saturation 95% on room air Pain level O on a scale of 0 to 10 scale

0930:

Temperature 36.5° C (97.7° F)

Heart rate 156/min Respiratory rate 28/min Blood pressure 110/62 mm Hg

Oxygen saturation 92% on room air

Pain level 5 on a scale of 0 to 10 scale


The nurse should anticipate a provider prescription for Medications due to the client's .



Hint : 🫀 “A-fib + fast HR → treat the rate/rhythm first.”

Correct Answers

  • Blank 1 Correct Option: Diltiazem
  • Blank 2 Correct Option: cardiac rhythm

Rationale :

🟦 The ECG shows atrial fibrillation with a rapid ventricular response (HR increased from 122/min to 156/min) and an irregular rhythm, which makes the priority problem the abnormal cardiac rhythm.

🟦 Diltiazem is a calcium channel blocker used to slow AV-node conduction, which helps control the ventricular rate in atrial fibrillation.

🟦 Rate control improves cardiac filling time, which can reduce symptoms like dyspnea, chest heaviness, and decreased oxygen saturation by improving overall cardiac output.

🟦 The client’s worsening status at 0930 (HR 156, RR 28, O₂ 92%, chest heaviness) fits a need to treat the unstable rhythm before focusing on secondary symptoms.

🟦 Although the client reports anxiety, the clinical pattern points to physiologic distress from A-fib with RVR, so a medication targeting rate/rhythm control is most appropriate to anticipate.

Albuterol nebulizer

🟦 Albuterol treats bronchospasm (e.g., asthma), but this client has clear lung sounds and the problem is not wheezing.

🟦 It can also increase heart rate, potentially worsening tachycardia in atrial fibrillation.

Alprazolam

🟦 Alprazolam may reduce anxiety, but it does not correct the dangerous cardiac rhythm causing the symptoms.

🟦 Sedation could also mask worsening cardiopulmonary status while the dysrhythmia continues.

Furosemide

🟦 Furosemide addresses fluid overload and edema, but the acute deterioration here is driven by rapid A-fib and falling oxygen saturation.

🟦 Non-pitting pedal edema is present, yet the immediate priority is rate control, not diuresis first.

Dopamine

🟦 Dopamine is used for hypotension/shock and can increase heart rate and myocardial workload.

🟦 With HR 156/min, dopamine could worsen tachyarrhythmia unless profound shock is present (not shown here).

Dyspnea

🟦 Dyspnea is present, but it is best explained by the rapid irregular rhythm reducing cardiac output and perfusion.

🟦 Treating the cardiac rhythm addresses the underlying trigger of dyspnea more directly.

Edema

🟦 Edema suggests chronic fluid issues from heart failure, not the sudden change in HR and symptoms at 0930.

🟦 The urgent issue is the new/worsening tachyarrhythmia.

Blood pressure

🟦 BP decreased from 132/68 to 110/62, but it is not the primary abnormality compared to A-fib with RVR.

🟦 The rhythm problem is the main driver requiring immediate targeted therapy.

Anxiety

🟦 Anxiety can occur as a response to hypoxia and palpitations, but it is not the primary cause of instability here.

🟦 Treating anxiety alone would not correct the arrhythmia producing the symptoms.


Distractor Analysis :

Rationale for Incorrect Options to be Available Soon

QLexNursing Calculator Click & Drag ×
AC
(
)
CE
π
e
φ
τ
Inv
sin-1
cos-1
tan-1
log
ln
!
deg
√
x²
x³
^
7
8
9
÷
4
5
6
×
1
2
3
-
0
.
exp
+
Rnd
Ans
=